H
Hooman Bakhshandeh
Researcher at Iran University of Medical Sciences
Publications - 146
Citations - 1592
Hooman Bakhshandeh is an academic researcher from Iran University of Medical Sciences. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 17, co-authored 130 publications receiving 981 citations. Previous affiliations of Hooman Bakhshandeh include Tehran University of Medical Sciences & University of Tehran.
Papers
More filters
Journal ArticleDOI
Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial.
Inspiration Investigators,Parham Sadeghipour,Azita Hajhossein Talasaz,Farid Rashidi,Babak Sharif-Kashani,Mohammad Taghi Beigmohammadi,Mohsen Farrokhpour,Seyed Hashem Sezavar,Pooya Payandemehr,Ali Dabbagh,Keivan Gohari Moghadam,Sepehr Jamalkhani,Hossein Khalili,Mahdi Yadollahzadeh,Taghi Riahi,Parisa Rezaeifar,Ouria Tahamtan,Samira Matin,Atefeh Abedini,Somayeh Lookzadeh,Hamid Reza Rahmani,Elnaz Zoghi,Keyhan Mohammadi,Pardis Sadeghipour,Homa Abri,Sanaz Hariri Tabrizi,Seyed Masoud Mousavian,Shaghayegh Shahmirzaei,Hooman Bakhshandeh,Ahmad Amin,Farnaz Rafiee,Elahe Baghizadeh,Bahram Mohebbi,Seyed Ehsan Parhizgar,Rasoul Aliannejad,Vahid Eslami,Alireza Kashefizadeh,Hessam Kakavand,Seyed Hossein Hosseini,Shadi Shafaghi,Samrand Fattah Ghazi,Atabak Najafi,David Jiménez,Aakriti Gupta,Aakriti Gupta,Mahesh V. Madhavan,Sanjum S. Sethi,Sahil A. Parikh,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Gregory Piazza,Ajay J. Kirtane,Benjamin W. Van Tassell,Paul P. Dobesh,Gregg W. Stone,Gregory Y.H. Lip,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Behnood Bikdeli,Behnood Bikdeli +63 more
TL;DR: In this paper, the authors evaluated the effects of intermediate-dose vs standard-dose prophylactic anticoagulation among patients with COVID-19 admitted to the intensive care unit (ICU).
Journal ArticleDOI
Impact of severe tricuspid regurgitation on long term survival.
Anita Sadeghpour,Mehri Hassanzadeh,Majid Kyavar,Hooman Bakhshandeh,Nasim Naderi,Behshid Ghadrdoost,Arezou Haghighat Talab +6 more
TL;DR: There is a significant increased incidence of mortality, prolonged hospitalization, and rehospitalization in symptomatic patients with severe TR, and more aggressive approach toward TV repair or replacement in these patients regardless of PAP and systolic function is recommended.
Journal ArticleDOI
Factors influencing prolonged ICU stay after open heart surgery.
TL;DR: Evaluating possible risk factors influencing prolonged ICU stay in 280 adult patients undergoing cardiac surgery in a tertiary care center for cardiovascular patients in Tehran, Iran found that up to 30% of the patients had a prolongedICU stay of > 96 hours.
Journal ArticleDOI
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studies.
Behnood Bikdeli,Azita Hajhossein Talasaz,Farid Rashidi,Babak Sharif-Kashani,Mohsen Farrokhpour,Hooman Bakhshandeh,S H Sezavar,Ali Dabbagh,Mohammad Taghi Beigmohammadi,Pooya Payandemehr,Mahdi Yadollahzadeh,Taghi Riahi,Hossein Khalili,Sepehr Jamalkhani,Parisa Rezaeifar,Atefeh Abedini,Somayeh Lookzadeh,Shaghayegh Shahmirzaei,Ouria Tahamtan,Samira Matin,Ahmad Amin,Seyed Ehsan Parhizgar,David Jiménez,Aakriti Gupta,Mahesh V. Madhavan,Sahil A. Parikh,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Bahram Mohebbi,Gregory Piazza,Ajay J. Kirtane,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Parham Sadeghipour +37 more
TL;DR: INSPIRATION and INSPIRATON-S studies will help address clinically-relevant questions for antithrombotic therapy and thromboinflammatory therapy in critically-ill patients with COVID-19 and test two independent hypotheses within a randomized control trial with 2 × 2 factorial design.
Journal ArticleDOI
Intermediate-Dose versus Standard-Dose Prophylactic Anticoagulation in Patients with COVID-19 Admitted to the Intensive Care Unit: 90-Day Results from the INSPIRATION Randomized Trial.
Behnood Bikdeli,Behnood Bikdeli,Azita Hajhossein Talasaz,Farid Rashidi,Hooman Bakhshandeh,Farnaz Rafiee,Parisa Rezaeifar,Elahe Baghizadeh,Samira Matin,Sepehr Jamalkhani,Ouria Tahamtan,Babak Sharif-Kashani,Mohammad Taghi Beigmohammadi,Mohsen Farrokhpour,Seyed Hashem Sezavar,Pooya Payandemehr,Ali Dabbagh,Keivan Gohari Moghadam,Hossein Khalili,Mahdi Yadollahzadeh,Taghi Riahi,Atefeh Abedini,Somayeh Lookzadeh,Hamid Reza Rahmani,Elnaz Zoghi,Keyhan Mohammadi,Pardis Sadeghipour,Homa Abri,Sanaz Hariri Tabrizi,Seyed Masoud Mousavian,Shaghayegh Shahmirzaei,Ahmad Amin,Bahram Mohebbi,Seyed Ehsan Parhizgar,Rasoul Aliannejad,Vahid Eslami,Alireza Kashefizadeh,Paul P. Dobesh,Hessam Kakavand,Seyed Hossein Hosseini,Shadi Shafaghi,Samrand Fattah Ghazi,Atabak Najafi,David Jiménez,Aakriti Gupta,Aakriti Gupta,Mahesh V. Madhavan,Sanjum S. Sethi,Sahil A. Parikh,Manuel Monreal,Manuel Monreal,Naser Hadavand,Alireza Hajighasemi,Majid Maleki,Saeed Sadeghian,Gregory Piazza,Ajay J. Kirtane,Benjamin W. Van Tassell,Gregg W. Stone,Gregory Y.H. Lip,Gregory Y.H. Lip,Harlan M. Krumholz,Samuel Z. Goldhaber,Parham Sadeghipour,Parham Sadeghipour +64 more
TL;DR: In this article, the authors report the final (90-day) results of the Intermediate versus Standard-dose Prophylactic anticoagulation In cRitically-ill pATIents with COVID-19: An opeN label randomized controlled trial (INSPIRATION) study.